Gv 2016 Gp, L.l.c. - Net Worth and Insider Trading

Gv 2016 Gp, L.l.c. Net Worth

The estimated net worth of Gv 2016 Gp, L.l.c. is at least $338 Million dollars as of 2024-11-13. Gv 2016 Gp, L.l.c. is the 10% Owner of IonQ Inc and owns about 14,707,933 shares of IonQ Inc (IONQ) stock worth over $338 Million. Details can be seen in Gv 2016 Gp, L.l.c.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gv 2016 Gp, L.l.c. has not made any transactions after 2022-04-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gv 2016 Gp, L.l.c.

To

Gv 2016 Gp, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gv 2016 Gp, L.l.c. owns 7 companies in total, including Magenta Therapeutics Inc (MGTA) , Arcus Biosciences Inc (RCUS) , and ARMO BioSciences Inc (ARMO) among others .

Click here to see the complete history of Gv 2016 Gp, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Gv 2016 Gp, L.l.c.

Ticker Comapny Transaction Date Type of Owner
MGTA Magenta Therapeutics Inc 2018-06-20 10 percent owner
RCUS Arcus Biosciences Inc 2018-03-14 10 percent owner
ARMO ARMO BioSciences Inc 2018-01-30 10 percent owner
LIMIT LIMIT 2017-11-15 10 percent owner
LIMIT LIMIT 2021-02-11 10 percent owner
LIMIT LIMIT 2022-04-11 10 percent owner
LIMIT LIMIT 2023-02-15 10 percent owner

Gv 2016 Gp, L.l.c. Latest Holdings Summary

Gv 2016 Gp, L.l.c. currently owns a total of 1 stock. Gv 2016 Gp, L.l.c. owns 14,707,933 shares of IonQ Inc (IONQ) as of April 11, 2022, with a value of $338 Million.

Latest Holdings of Gv 2016 Gp, L.l.c.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IONQ IonQ Inc 2022-04-11 14,707,933 23.01 338,429,538

Holding Weightings of Gv 2016 Gp, L.l.c.


Gv 2016 Gp, L.l.c. Form 4 Trading Tracker

According to the SEC Form 4 filings, Gv 2016 Gp, L.l.c. has made a total of 1 transactions in IonQ Inc (IONQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in IonQ Inc is the sale of 544,249 shares on April 11, 2022, which brought Gv 2016 Gp, L.l.c. around $6 Million.

Insider Trading History of Gv 2016 Gp, L.l.c.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gv 2016 Gp, L.l.c. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gv 2016 Gp, L.l.c. Ownership Network

Ownership Network List of Gv 2016 Gp, L.l.c.

No Data

Ownership Network Relation of Gv 2016 Gp, L.l.c.

Insider Network Chart

Gv 2016 Gp, L.l.c. Owned Company Details

What does Magenta Therapeutics Inc do?

Who are the key executives at Magenta Therapeutics Inc?

Gv 2016 Gp, L.l.c. is the 10 percent owner of Magenta Therapeutics Inc. Other key executives at Magenta Therapeutics Inc include director & 10 percent owner Peter Evan Harwin , director & 10 percent owner Tomas Kiselak , and director & 10 percent owner Fairmount Funds Management Llc .

Magenta Therapeutics Inc (MGTA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Magenta Therapeutics Inc Insider Transactions

No Available Data

Gv 2016 Gp, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Gv 2016 Gp, L.l.c.. You might contact Gv 2016 Gp, L.l.c. via mailing address: 1600 Amphitheatre Parkway, Mountain View Ma 94043.